FdaApplication
NDA 203595
Identifiers
- fda_app_no: NDA203595
Properties
| Property | Value |
|---|---|
| applicant_name | BRAINTREE LABORATORIES INC |
| application_type | NDA |
| approval_date | 2013-01-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUCLEAR | MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE | 1.6GM/BOT,3.13GM/BOT,17.5GM/BOT,N/A,N/A,N/A,N/A;N/A,N/A,N/A,210GM,0.74GM,2.86GM,5.6GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;ORAL |
1 product